We are live on ! Find out more
INMB icon

INmune Bio
INMB

52 hedge funds and large institutions have $32.2M invested in INmune Bio in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,384% more call options, than puts

Call options by funds: $653K | Put options by funds: $44K

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

55% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 11

24% more capital invested

Capital invested by funds: $26M → $32.2M (+$6.23M)

8% more funds holding

Funds holding: 48 → 52 (+4)

2.41% more ownership

Funds ownership: 12.8% → 15.21% (+2.4%)

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
11
Closed
7
Calls
$653K
Puts
$44K
Net Calls
+$609K
Net Calls Change
+$331K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.63M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.34M
3
Goldman Sachs
Goldman Sachs
New York
+$1.06M
4
MCM
MAI Capital Management
Ohio
+$1.01M
5
Jane Street
Jane Street
New York
+$373K

Top Sellers

Rank Fund Capital Flow
1
QCG
Quadrant Capital Group
Ohio
-$676K
2
Citadel Advisors
Citadel Advisors
Florida
-$409K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$274K
4
6CM
683 Capital Management
New York
-$217K
5
BlackRock
BlackRock
New York
-$215K
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
26
Balyasny Asset Management
Illinois
$236K -$38.8K -3,211 -14%
BHCM
27
Brevan Howard Capital Management
Jersey
$193K +$198K +16,422 New
MTIM
28
Marathon Trading Investment Management
Pennsylvania
$170K +$175K +14,500 New
Squarepoint
29
Squarepoint
New York
$158K +$162K +13,441 New
PAS
30
Point72 Asia (Singapore)
Singapore
$158K +$162K +13,438 New
Osaic Holdings
31
Osaic Holdings
Arizona
$144K +$19K +1,570 +15%
YIH
32
Y-Intercept (HK)
Hong Kong
$130K +$134K +11,059 New
LCM
33
Laurion Capital Management
New York
$129K – – –
FAIM
34
Financial Advocates Investment Management
Washington
$123K -$24.2K -2,000 -16%
NA
35
NewEdge Advisors
Louisiana
$123K +$604 +50 +0.5%
BPA
36
Beacon Pointe Advisors
California
$122K – – –
LPL Financial
37
LPL Financial
California
$118K -$906 -75 -0.7%
Bank of America
38
Bank of America
North Carolina
$103K -$64.6K -5,343 -38%
CSS
39
Cubist Systematic Strategies
Connecticut
$56.2K +$57.8K +4,782 New
TRCT
40
Tower Research Capital (TRC)
New York
$26.5K +$8.71K +721 +47%
LSA
41
Leonteq Securities AG
Switzerland
$18.8K – – –
VNA
42
Valley National Advisers
Pennsylvania
$11K – – –
CA
43
Continuum Advisory
Idaho
$10.8K +$12.1K +1,000 New
Fidelity Investments
44
Fidelity Investments
Massachusetts
$6.87K +$6.04K +500 +588%
CA
45
Clearstead Advisors
Ohio
$4.86K +$846 +70 +17%
FDCDDQ
46
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.7K – – –
NS
47
NBC Securities
Alabama
$3K – – –
IA
48
IFP Advisors
Florida
$2.16K – – –
Wells Fargo
49
Wells Fargo
California
$1.73K +$24 +2 +1%
Citadel Advisors
50
Citadel Advisors
Florida
$353 -$409K -33,821 -100%
1
2
3

INMB Hedge Fund Activity: Q1 2024 in Review

52 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q1 2024, worth a combined $32.2M — up 24% from $26M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new INMB positions and 7 closed out — a net gain of 4 holders — while 17 added to existing stakes and 11 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.63M. The largest seller was Quadrant Capital Group, exiting entirely with an estimated $676K sold.

  • 52 institutional investors held INmune Bio (INMB) as of Q1 2024, up from 48 in Q4 2023.
  • Funds reported $32.2M of INmune Bio stock for Q1 2024, up 24% quarter-over-quarter.
  • 11 funds opened new INmune Bio positions in Q1 2024 and 7 closed out, a net change of +4 holders.
  • The largest INmune Bio buyer in Q1 2024 was Millennium Management, an estimated $1.63M added.
  • The largest INmune Bio seller in Q1 2024 was Quadrant Capital Group, an estimated $676K sold.

Based on aggregated 13F filings for Q1 2024.